drugset / Trial / NCT01427387

A Study to Evaluate Safety of Multiple Dose of ASP0456 in Healthy Subjects

NCT01427387

Phase 1 Completed 44 enrolled Astellas Pharma Inc
RandomizedParallel-groupTriple-blind

Summary

A study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of multiple ascending dose of ASP0456 in non-elderly healthy subjects. Two dosing condition, pre-prandial and postprandial administrations, is compared.

Timeline

Start
2011-06
Primary completion
2011-09
Completion
2011-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Linaclotide Peptide Oral

Indications

No indication recorded.